BSE Live
Nov 07, 16:01Prev. Close
442.10
Open Price
441.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:55Prev. Close
441.75
Open Price
436.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Venus Remedies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -8.10 | -23.15 | -24.87 | -14.88 | 1.48 | |
| Diluted EPS (Rs.) | -8.10 | -23.15 | -24.87 | -14.88 | 1.48 | |
| Cash EPS (Rs.) | 17.84 | 4.38 | 2.54 | 18.78 | 37.91 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 262.01 | 269.42 | 293.23 | 314.92 | 382.47 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 262.01 | 269.42 | 293.23 | 314.92 | 382.47 | |
| Revenue from Operations/Share (Rs.) | 274.94 | 260.81 | 301.75 | 324.13 | 365.56 | |
| PBDIT/Share (Rs.) | 37.37 | 31.29 | 33.81 | 42.94 | 72.69 | |
| PBIT/Share (Rs.) | 11.44 | 3.76 | 6.40 | 10.32 | 36.26 | |
| PBT/Share (Rs.) | -6.51 | -24.09 | -22.31 | -17.53 | 3.07 | |
| Net Profit/Share (Rs.) | -8.10 | -23.15 | -24.87 | -13.84 | 1.48 | |
| NP After MI And SOA / Share (Rs.) | -8.10 | -23.15 | -24.87 | -13.84 | 1.48 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 13.59 | 11.99 | 11.20 | 13.24 | 19.88 | |
| PBIT Margin (%) | 4.15 | 1.44 | 2.11 | 3.18 | 9.91 | |
| PBT Margin (%) | -2.36 | -9.23 | -7.39 | -5.40 | 0.83 | |
| Net Profit Margin (%) | -2.94 | -8.87 | -8.24 | -4.26 | 0.40 | |
| NP After MI And SOA Margin (%) | -2.94 | -8.87 | -8.24 | -4.26 | 0.40 | |
| Return on Networth/Equity (%) | -3.09 | -8.59 | -8.48 | -4.39 | 0.38 | |
| Return on Capital Employed (%) | 3.36 | 0.98 | 1.51 | 2.24 | 0.26 | |
| Return on Assets (%) | -1.56 | -3.89 | -4.08 | -2.23 | 0.20 | |
| Total Debt/Equity (X) | 0.49 | 0.69 | 0.71 | 0.72 | 0.72 | |
| Asset Turnover Ratio (%) | 53.21 | 43.92 | 49.60 | 52.29 | 49.62 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.32 | 1.01 | 1.13 | 1.32 | 1.43 | |
| Quick Ratio (X) | 0.67 | 0.47 | 0.53 | 0.60 | 0.69 | |
| Inventory Turnover Ratio (X) | 2.40 | 2.26 | 2.70 | 2.85 | 2.92 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 1.06 | 0.18 | 0.22 | 0.37 | 1.09 | |
| Interest Coverage Ratios (Post Tax) (%) | 1.06 | 0.18 | 0.22 | 0.37 | 1.09 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 183.27 | 266.93 | 335.74 | 398.43 | 408.56 | |
| EV/Net Operating Revenue (X) | 0.54 | 0.83 | 0.90 | 1.00 | 0.98 | |
| EV/EBITDA (X) | 3.97 | 6.91 | 8.05 | 7.52 | 4.91 | |
| MarketCap/Net Operating Revenue (X) | 0.08 | 0.13 | 0.22 | 0.30 | 0.24 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.09 | 0.12 | 0.22 | 0.31 | 0.23 | |
| Price/Net Operating Revenue | 0.08 | 0.13 | 0.22 | 0.30 | 0.24 | |
| Earnings Yield | -0.36 | -0.70 | -0.38 | -0.14 | 0.02 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y